Related Articles
Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice
Serum miR‑29 is increased in mice with early liver fibrosis
Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice
Prevention and regression of non-alcoholic steatohepatitis (NASH) in a rat model by metabosartan, telmisartan
Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis